![Jason Litten](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Litten
Directeur Technique/Scientifique/R&D chez
GENELUX CORPORATION
Profil
Jason B. Litten is Chief Medical Officer at Genelux Corp.
since 2026.
Formerly, Dr. Litten was Chief Medical Officer at Chimeric Therapeutics Ltd. (Australia) from 2022 to 2025, Chief Medical Officer at Artiva Biotherapeutics, Inc. from 2019 to 2022, Chief Medical Officer at Optera Therapeutics Corp.
in 2019, Vice President-Clinical Development at Juno Therapeutics, Inc. from 2016 to 2018, Vice President-Clinical Development at Clovis Oncology, Inc. Education includes a doctorate from Emory University and an undergraduate degree from Cornell University.
Postes actifs de Jason Litten
| Sociétés | Poste | Début |
|---|---|---|
| GENELUX CORPORATION | Directeur Technique/Scientifique/R&D | 02/01/2026 |
Anciens postes connus de Jason Litten
| Sociétés | Poste | Fin |
|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Directeur Technique/Scientifique/R&D | 23/12/2025 |
| ARTIVA BIOTHERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 06/06/2022 |
Optera Therapeutics Corp. | Directeur Technique/Scientifique/R&D | 01/06/2019 |
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01/05/2018 |
| CLOVIS ONCOLOGY, INC. | Corporate Officer/Principal | - |
Formation de Jason Litten
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Genelux Corp.
 Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
Emory University
 Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
Chimeric Therapeutics Ltd. (Australia)
 Chimeric Therapeutics Ltd. (Australia) BiotechnologyHealth Technology Develops cell therapies for the tumors | Health Technology |
Optera Therapeutics Corp. |
